Baxter Biopharma solutions. DEERFIELD, Ill., AND CAMBRIDGE, MASS. - March 8, 2021 Baxter International Inc.
(NYSE: BAX), a global leader in sterile medication production and delivery, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that they have entered into an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of the Moderna COVID-19 Vaccine in 2021. Recipharm. Catalent. Rovi.